The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation

Journal of Cardiovascular Pharmacology
H ShimokawaA Takeshita

Abstract

Endothelium-dependent relaxations are achieved by a combination of endothelium-derived prostacyclin (PGI2), nitric oxide (NO), and endothelium-derived hyperpolarizing factor (EDHF). However, it remains to be fully clarified whether the relative contribution of these three mechanisms to endothelium-dependent relaxations varies as a function of the vessel size. This study was designed to clarify this point. Acetylcholine (ACh)-induced endothelium-dependent relaxations were examined in isolated blood vessels taken from the aorta and the proximal and distal mesenteric arteries of the rat. The contributions of PGI2, NO, and EDHF were evaluated by the inhibitory effects of indomethacin, N omega-nitro-L-arginine methyl ester (L-NAME) in the presence of indomethacin, and KCl in the presence of indomethacin and L-NAME, respectively. The membrane potentials were recorded with microelectrodes. The expression of endothelial No synthase (eNOS) was examined by both immunostaining and immunoblotting. The contribution of PGI2 was negligible in three different-sized blood vessels. The contribution of NO was most prominent in the aorta, whereas that of EDHF was most prominent in the distal mesenteric arteries. The resting membrane potential was ...Continue Reading

References

Dec 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·T HayashiG Chaudhuri
Jan 1, 1990·Reviews of Physiology, Biochemistry and Pharmacology·E Bassenge, G Heusch
Jul 5, 1990·The New England Journal of Medicine·J A PanzaS E Epstein
Mar 1, 1988·British Journal of Pharmacology·M Feletou, P M Vanhoutte
Jun 1, 1989·Circulation Research·C BoulangerP M Vanhoutte
Jul 1, 1989·Circulation Research·K KauserD R Harder
Aug 1, 1988·Trends in Pharmacological Sciences·S G Taylor, A H Weston
Dec 1, 1993·Stroke; a Journal of Cerebral Circulation·Z G ZhangU Förstermann
Apr 1, 1994·Journal of Cardiovascular Pharmacology·R N PianaF W Sellke
Nov 1, 1994·Circulation·T TagawaA Takeshita
Sep 1, 1994·European Heart Journal·M TsutsuiS Okamatsu
Jan 1, 1993·American Journal of Respiratory Cell and Molecular Biology·T Nagao, P M Vanhoutte
Oct 1, 1995·Internal Medicine·H Shimokawa, A Takeshita

❮ Previous
Next ❯

Citations

Oct 28, 2010·Naunyn-Schmiedeberg's Archives of Pharmacology·Asami MoriKunio Ishii
Feb 9, 2010·Pflügers Archiv : European journal of physiology·Hiroaki Shimokawa
Mar 13, 2010·Pflügers Archiv : European journal of physiology·Valérie B Schini-KerthThierry Chataigneau
Apr 13, 2010·Pflügers Archiv : European journal of physiology·Andreas J Flammer, Thomas F Lüscher
Mar 24, 2006·Cardiovascular Drugs and Therapy·Sadi S OzdemCoskun Usta
Apr 30, 2008·Purinergic Signalling·Manuela MoratoAntónio Albino-Teixeira
Jun 19, 2004·The International Journal of Biochemistry & Cell Biology·S D ChauhanA Ahluwalia
Jan 20, 2004·European Journal of Pharmacology·Junko OguraToshihiko Murayama
Mar 18, 2004·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Michel Félétou, Paul M Vanhoutte
Mar 18, 2004·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Tudor M GriffithDavid H Edwards
Jun 9, 2005·Vascular Pharmacology·Sadi S OzdemOguz K Baskurt
Sep 21, 2000·European Journal of Pharmacology·H M CrauwelsH Bult
Jan 4, 2001·European Journal of Pharmacology·S IidaK Kanmatsuse
Mar 7, 2001·European Journal of Pharmacology·A Timar-Peregrin, R G Guy
Oct 12, 2000·Nihon rinsho. Japanese journal of clinical medicine·Y SaitoR Nagai
Aug 5, 1998·Pharmacology & Therapeutics·E Thorin, S M Shreeve
Mar 31, 2000·Trends in Pharmacological Sciences·J Quilley, J C McGiff
Oct 16, 2002·Trends in Pharmacological Sciences·Rudi BusseArthur H Weston
Jun 24, 2003·European Journal of Obstetrics, Gynecology, and Reproductive Biology·J C GillhamP N Baker
Aug 26, 2000·Cardiovascular Surgery : Official Journal of the International Society for Cardiovascular Surgery·S PesićN Munjas
Mar 10, 2001·Trends in Cardiovascular Medicine·I Fleming
Jul 18, 2002·BJOG : an International Journal of Obstetrics and Gynaecology·Christine AngMary Ann Lumsden
Sep 10, 2008·The British Journal of Nutrition·Sanéo ThioubFrançois Guerrero
Jul 1, 2009·The British Journal of Nutrition·Rosalia Rodriguez-RodriguezValentina Ruiz-Gutierrez
Jul 13, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Pieter LemkensJo G R De Mey
Mar 2, 1999·British Journal of Pharmacology·T ChataigneauP M Vanhoutte
Dec 22, 1999·British Journal of Pharmacology·F Pérez-VizcaínoJ Tamargo
Jul 6, 2000·British Journal of Pharmacology·J M DoughtyP D Langton
Nov 18, 2000·British Journal of Pharmacology·K ImaedaH Suzuki
Sep 5, 2002·British Journal of Pharmacology·Nelson C FariasTherezinha B Paiva

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.